×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Why Diabetes Stock Insulet Soared 27.3% in May
Yahoo News Singapore
What happened. Insulet (NASDAQ: PODD) stock rocketed 27.3% higher in May, according to data from S&P Global Market Intelligence.
11 hours ago
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take...
2 days ago
Here's Why You Should Retain Insulet (PODD) Stock for Now
MSN
Insulet Corporation PODD is poised to gain in the coming quarters owing to the strength of its revolutionary offering, the Omnipod 5 Automated Insulin...
2 days ago
Is Insulet (NASDAQ:PODD) A Risky Investment?
Simply Wall Street
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.
5 days ago
Insulet annual revenue reaches new heights, growing 30% on Omnipod 5 boost
Fierce Biotech
Insulet annual revenue reaches new heights, growing 30% on Omnipod 5 boost ... Once again, Insulet has broken its own records for annual revenue...
2 months ago
Insulet (PODD) Gains But Lags Market: What You Should Know
Yahoo Lifestyle Canada
Insulet (PODD) closed at $312.90 in the latest trading session, marking a +0.52% move from the prior day.
6 hours ago
DexCom, Insulet, Tandem seen benefitting the most in diabetes survey
Seeking Alpha
A recent survey by Wells Fargo reveals Dexcom, Insulet Corp., and Tandem Diabetes Care as the top beneficiaries in the diabetes care market.
5 days ago
Cwm LLC Sells 95 Shares of Insulet Co. (NASDAQ:PODD)
Defense World
Read Cwm LLC Sells 95 Shares of Insulet Co. (NASDAQ:PODD) at Defense World.
1 day ago
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
Business Wire
--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its...
1 month ago
Insulet applauds as UK begins artificial pancreas rollout
Drug Delivery Business
NHS England said tens of thousands of children and adults with type 1 diabetes in the country will receive an artificial pancreas. The...
1 month ago